Eversept Partners as of Dec. 31, 2022
Portfolio Holdings for Eversept Partners
Eversept Partners holds 60 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| GSK Sponsored Adr (GSK) | 17.3 | $198M | 5.6M | 35.48 | |
| Horizon Therapeutics Pub L SHS | 10.6 | $121M | 1.1M | 113.80 | |
| Natera (NTRA) | 9.4 | $108M | 2.7M | 40.17 | |
| Sanofi Sponsored Adr (SNY) | 6.8 | $78M | 1.6M | 48.43 | |
| United Therapeutics Corporation (UTHR) | 5.7 | $65M | 233k | 278.09 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.0 | $46M | 5.0M | 9.12 | |
| Danaher Corporation (DHR) | 3.8 | $43M | 163k | 265.67 | |
| Syndax Pharmaceuticals (SNDX) | 3.6 | $41M | 1.6M | 25.45 | |
| Biogen Idec (BIIB) | 3.3 | $38M | 137k | 276.92 | |
| Catalent | 2.7 | $31M | 692k | 45.01 | |
| Illumina (ILMN) | 2.5 | $28M | 140k | 202.20 | |
| Spdr Ser Tr S&p Biotech (XBI) | 2.2 | $25M | 306k | 83.00 | |
| Celldex Therapeutics Com New (CLDX) | 2.2 | $25M | 559k | 44.57 | |
| Envista Hldgs Corp (NVST) | 1.9 | $22M | 642k | 33.67 | |
| Centene Corporation (CNC) | 1.5 | $18M | 215k | 82.01 | |
| Haleon Spon Ads (HLN) | 1.3 | $15M | 1.9M | 8.00 | |
| Anthem Inc opt | 1.3 | $14M | 28k | 512.97 | |
| Icon SHS (ICLR) | 1.1 | $13M | 67k | 194.25 | |
| Avantor (AVTR) | 1.1 | $13M | 600k | 21.09 | |
| Tenet Healthcare Corp Com New (THC) | 1.1 | $12M | 255k | 48.79 | |
| Seres Therapeutics | 1.1 | $12M | 2.2M | 5.60 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $11M | 276k | 39.43 | |
| Humana (HUM) | 0.9 | $11M | 21k | 512.96 | |
| BioCryst Pharmaceuticals (BCRX) | 0.9 | $10M | 881k | 11.48 | |
| Community Health Systems (CYH) | 0.9 | $10M | 2.3M | 4.32 | |
| Repligen Corporation (RGEN) | 0.8 | $9.7M | 57k | 169.31 | |
| Ionis Pharmaceuticals (IONS) | 0.8 | $9.1M | 241k | 37.77 | |
| Model N (MODN) | 0.8 | $8.8M | 218k | 40.56 | |
| Vaxcyte (PCVX) | 0.7 | $8.6M | 179k | 47.95 | |
| Liquidia Corporation Com New (LQDA) | 0.7 | $8.2M | 1.3M | 6.37 | |
| Apellis Pharmaceuticals (APLS) | 0.7 | $8.0M | 155k | 51.71 | |
| Vera Therapeutics Cl A (VERA) | 0.7 | $8.0M | 411k | 19.35 | |
| Iveric Bio | 0.7 | $7.5M | 351k | 21.41 | |
| Taro Pharmaceutical Inds SHS (TARO) | 0.6 | $6.5M | 226k | 29.04 | |
| Puma Biotechnology (PBYI) | 0.6 | $6.4M | 1.5M | 4.23 | |
| Merck & Co Call Option (MRK) | 0.5 | $5.4M | 49k | 110.95 | |
| Evolus (EOLS) | 0.5 | $5.4M | 714k | 7.51 | |
| Incyte Corporation (INCY) | 0.4 | $5.1M | 64k | 80.32 | |
| Guardant Health (GH) | 0.3 | $4.0M | 146k | 27.20 | |
| Amarin Corp Spons Adr New | 0.3 | $4.0M | 3.3M | 1.21 | |
| Merus N V (MRUS) | 0.2 | $2.9M | 185k | 15.47 | |
| Aerovate Therapeutics (AVTE) | 0.2 | $2.7M | 91k | 29.30 | |
| Pliant Therapeutics (PLRX) | 0.2 | $2.7M | 137k | 19.33 | |
| Cabaletta Bio (CABA) | 0.2 | $2.6M | 283k | 9.25 | |
| Biohaven (BHVN) | 0.2 | $2.6M | 186k | 13.88 | |
| Iqvia Holdings (IQV) | 0.2 | $2.2M | 11k | 204.89 | |
| Agilent Technologies Inc C ommon (A) | 0.2 | $1.8M | 12k | 149.88 | |
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.1 | $1.7M | 831k | 1.99 | |
| Xoma Corp Del Com New (XOMA) | 0.1 | $1.6M | 87k | 18.40 | |
| PerkinElmer (RVTY) | 0.1 | $1.6M | 11k | 140.22 | |
| Bio-techne Corporation (TECH) | 0.1 | $1.4M | 17k | 82.88 | |
| Argenx Se Sponsored Adr (ARGX) | 0.1 | $1.3M | 3.5k | 378.83 | |
| Aadi Bioscience (WHWK) | 0.1 | $1.3M | 102k | 12.83 | |
| Heska Corp Com Restrc New | 0.1 | $1.2M | 20k | 62.16 | |
| Gohealth Cl A New (GOCO) | 0.0 | $528k | 51k | 10.45 | |
| Fate Therapeutics (FATE) | 0.0 | $440k | 44k | 10.09 | |
| Affimed Therapeutics B V | 0.0 | $410k | 330k | 1.24 | |
| Gossamer Bio (GOSS) | 0.0 | $335k | 154k | 2.17 | |
| Glycomimetics | 0.0 | $305k | 101k | 3.03 | |
| Ac Immune Sa SHS (ACIU) | 0.0 | $254k | 125k | 2.04 |
